The role of fibronectin and nitric oxide (NO) in gastrointestinal cancers

Hepato-Gastroenterology

Volumn 52, Issue 61, 2005, Pages 119-122

  Hazar, Burhan ^a,c   Polat, Gürbüz ^a   Bagdatoglu, Özlen ^a   Seyrek, Ertugrul ^a   Tezcan, Yilmaz ^b   Kanik, Arzu ^a  

^a MERSIN UNIVERSITY   (Turkey)

^b Mersin Community Hospital   (Turkey)

^c NONE   (Turkey)

Author keywords

Colorectal cancer; Fibronectin; Gastric cancer; Nitric oxide (NO)

Indexed keywords

FIBRONECTIN; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR;

AGE; ARTICLE; CANCER SURVIVAL; COLON CANCER; COLORECTAL CANCER; CONTROLLED STUDY; DIGESTIVE SYSTEM CANCER; FEMALE; GENDER; HUMAN; IMMUNOCHEMISTRY; MAJOR CLINICAL STUDY; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN FUNCTION; STOMACH CANCER;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; FEMALE; FIBRONECTINS; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; NITRIC OXIDE; STOMACH NEOPLASMS; SURVIVAL RATE;

EID: 14144253105     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Jemal A, Thomas A, Murray T, Thun M: Cancer Statistics, 2002. CA Cancer J Clin 2002; 52:23-47.
2. Rosen N: Cancer of the gastrointestinal tract. In: DeVita VT, Hellman S, Rosenberg SA (Eds.). Cancer: Principles and practice of oncology. 5th Edition. Philadelphia: Lippincott-Raven, 1997; pp. 971-980.
3. Mignatti P, Rifkin DB: Biology and biochemistry of proteinases in tumor invasion. Physiol Rev 1993; 73(1):161-195.
4. Robert JL: Fibronectin in malignancy effect of aging. Cancer Biology 2002; 12:187-195.
5. + isoform by human and experimental colorectal cancer. Contribution of cancer cells and tumor-associated myofibroblasts. Am J Pathol 1996; 148:579-592.
6. Ito H, Miyazaki M, Nishimura F, Nakajima N: Secretion of extracellular matrix (fibronectin), growth factor (transforming growth factor β) and protease (catepsin D) by hepatoma cells. Oncology 2000; 58:261-271.
7. Conejo-Lopez MT, Olmo N, Turnay J, et al: Interaction of fibronectin with human colon adenocarcinoma cells: Effect on the in vivo tumorigenic capacity. Oncology 2002; 62:371-380.
8. Moncada S, Higgs A: The L-arginine-nitric oxide pathway. N Engl J Med 1993; 329:2002-2012.
9. Jenkins DC, Charles IG, Thomsen LL, et al: Roles of nitric oxide in tumor growth. Proc Natl Acad Sci USA 1995; 92:4392-4396.
10. Jaiswal M, LaRusso NF, Gores GJ: Nitric oxide in gastrointestinal epithelial cell carcinogenesis: Linking inflammation to oncogenesis. Am J Physiol 2001; 281(3):G626-634.
11. Thomsen LL, Miles DW, Hipperfield L, et al: Nitric oxide synthase activity in breast cancer. Br J Cancer 1995; 72(1):41-44.
12. Bakan E, Taysi S, Polat MF, et al: Nitric oxide levels and lipid peroxidation in plasma of patients with gastric cancer. Jpn J Clin Oncol 2002; 32(5):162-166.
13. Thomsen LL, Lawton FG, Knowles RG, et al: Nitric oxide synthase activity in human gynecological cancer. Cancer Res 1994; 54(5):1352-1354.
14. Roberts PJ, Riley GP, Morgan K, et al: The physiological expression of inducible nitric oxide synthase (iNOS) in the human colon. J Clin Pathol 2001; 54(4):293-297.
15. Moochhala S, Chhatwal VJ, Chan ST, et al: Nitric oxide synthase activity and expression in human colorectal cancer. Carcinogenesis 1996; 17(5):1171-1174.
16. Akiyama SK, Olden K, Yamada KM: Fibronectin and integrins in invasion and metastasis. Cancer Metastasis Rev 1995; 14(3):173-189.
17. Moro L, Colombi M, Molinari Tasatti MP, Barlati S: Study of fibronectin and mRNA in human laryngeal and ectocervical carcinomas by in situ hybridization and image analysis. Int J Cancer 1992; 51(5):692-697.
18. Suzuki K, Ono T, Umeda M, Itoh H: Secretion of cell-adhesion-promoting factors, fibronectin, fibronectin fragments and a 53-kDa protein, by human rectal adenocarcinoma cells. Int J Cancer 1992; 52(5):818-826.
19. Sobin LH, Wittekind CH (eds.): In: TNM classification of malign tumors, 5th Edition. International Union Against Cancer. New York: Wiley-Liss, 1997.
20. Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR: Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal Biochem 1982; 126:131-138.
21. Siegert A, Rosenberg C, Schimitt WD, et al: Nitric oxide of human colorectal adenocarcinoma cell lines promotes tumor cell invasion. Br J Cancer 2002; 86(8):1310-1315.
22. Rao CV, Indranie C, Simi B, et al: Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administrated alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor. Cancer Res 2002; 62:165-170.
23. Cianci F, Cortesini C, Fontappie O, et al: Inducible nitric oxide synthase expression in human colorectal cancer: correlation with tumor angiogenesis. Am J Pathol 2003; 162(3):793-801.
24. Lagares-Garcia JA, More RA, Collier B, et al: Nitric oxide synthase as a marker in colon cancer. Am Surg 2001; 67(7):709-713.
25. Feng CW, Wang LD, Jiao LH, et al: Expression of p53, inducible nitric oxide synthase and vascular endothelial growth factor in gastric precancerous and cancerous lesions: correlation with clinical faetures. BMC Cancer 2002; 2:1-7.
26. Rajnakova A, Moochhala S, Gob, PMY, Ngoi SS: Expression of inducible nitric oxide synthase, cyclooxygenase, and p53 in different stages of human gastric cancer. Cancer Letters 2001; 172:177-185.
27. Koh E, Noh SH, Lee YD, et al: Differential expression of nitric oxide synthase in human stomach cancer. Cancer Letters 1999; 146:173-180.